Health and Medicine

August 5, 2013

Vanderbilt scientists discover potential new way to treat anxiety

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week.

By Bill Snyder
Older woman shopping
August 1, 2013

Cognitive complaints, Alzheimer’s risk studied

A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years.

By VUMC News and Communications
August 1, 2013

Study explores race differences of lung cancer risk

Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups.

By VUMC News and Communications
August 1, 2013

Case study explores stroke, meningitis link

A case series by researchers at Vanderbilt University Medical Center examines three patients transferred here with ischemic stroke who later received a diagnosis of fungal meningitis attributed to tainted injections for low back pain, part of a multi-state outbreak.

By VUMC News and Communications
July 31, 2013

Factor’s role in long bone development

Insight into how the protein neurofibromin participates in the signaling pathway that produces the body’s long bones has implications for fracture healing in some patients.

By Leigh MacMillan
July 29, 2013

Motor protein revs up cell division

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.

By Leigh MacMillan
July 26, 2013

Reducing fatal rhythms after heart attack

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
By Courtney M. Campbell
July 25, 2013

App helps children manage their health care routines

Adults have calendar applications on all their digital devices to remind them of appointments and what’s next on their agenda.
By Christina Echegaray
July 25, 2013

Award bolsters study of bladder cancer chemo resistance

David DeGraff, Ph.D., has received the 2013 BCAN Young Investigator Award for Bladder Cancer Research.
By VUMC News and Communications
July 25, 2013

‘Bionic eye’ new option for retinitis pigmentosa patients

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
By Jessica Pasley
July 25, 2013

Pollen counts boost risk of rare drug reaction: study

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.
By VUMC News and Communications
July 25, 2013

Visualizing data on network ‘maps’

The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification.
By Leigh MacMillan
July 17, 2013

Probing roles of a cell death protein

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.
By Leigh MacMillan
1 … 154 155 156 157 158 … 197